Programme supporters
We would like to thank our industry partners for their support of this programme, without which the study day may not have been possible.
Face-to-face workshop
Orion Pharma (UK) Ltd have provided a sponsorship grant towards this independent programme. They have had no editorial input into or control over the agenda, content development or choice of speakers, except for the Orion Pharma (UK) Ltd sponsored symposia presentation which has been fully funded and organised by Orion Pharma (UK) Ltd including choice of speaker, content development and all associated materials.
Exhibitors
Cipla (EU) Limited 3rd floor, 364-366 Kensington High Street, London, W14 8NS, United Kingdom |
Cipla UK Registered Office Dixcart House, Addlestone Road, Bourne Business Park Addlestone, Surrey, KT15 2LE, United Kingdom |
Tel: 07488713227 | |
Email: Ghazala.sial@cipla.com | |
Web: Cipla UK | |
Cipla (EU) Limited is a wholly-owned subsidiary of Cipla Limited, a global pharmaceutical company ranked No.2 (in FY’20) in the worldwide sale of respiratory inhalers by volume. (Cipla Annual Report 2021-22)
In 2013, Cipla commenced direct-to-market operations in the UK. Since then we have added a range of respiratory products, hospital products and have entered the oncology segment. Today, economies of scale and support from our global R&D and manufacturing teams has enabled us to deliver high quality products, and with product introductions, we aim to expand our range of branded and generic products in the UK. About Our Chairman Dr Y K Hamied continued his association with his alma mater, the University of Cambridge, even after his education. He has contributed towards certain facilities like the Yusuf Hamied Centre at Christ’s College and a laboratory at the Department of Chemistry, where the Yusuf Hamied 1702 Chair of Chemistry was named after him in 2018. In 2011, he had the exceptional honour of having a bust of himself unveiled at Christ’s College, University of Cambridge, making him the second Indian since eminent scientist Dr Jagadish Chandra Bose to have such an honour. In 2014, the University of Cambridge awarded him a D.Sc., the highest scientific degree that the University can bestow. In 2017, Columbia University’s Mailman School of Public Health conferred the ‘Public Health Hero Award’ on Dr Hamied. Dr Hamied has been the recipient of several lifetime achievement awards, he is an honorary fellow of the Royal Society and the Royal Society of Chemistry, and is a frequent presence on high-level international panels on healthcare. |
Clement Clarke International Cynon Valley Business Park Cwm Cynon Business Park Mountain Ash Wales CF45 4ER |
Tel: 01443 808 875 / 01443 804 999 |
Email: resp@clement-clarke.com |
Web: https://www.clement-clarke.com |
Clement Clarke International (CCI), a UK based respiratory medical device manufacturer with over 100 years of history, was recently acquired by Flexicare. This acquisition provides CCI with an excellent position to further develop their high quality, accurate devices and to springboard expansion of their respiratory diagnosis, monitoring and treatment portfolio worldwide.
Devices such as the In-check Dial G16 inhaler technique assessment device, the “Gold Standard” Mini-Wright Peak Flow Meter and the CCI innovative Inhaler Technique Training Toolkit help correct the well-published significant problem of “up to 94% of patients with asthma and COPD not using their inhalers correctly”. |
Wockhardt UK Limited Ash Road North Wrexham Industrial Estate Wrexham LL13 9UF UK |
Tel: 01979 661261 |
Email: enquiries@wockhardt.co.uk |
Web: www.wockhardt.co.uk |
Wockhardt UK is a leading supplier of medicines to the NHS and has been partnering with the NHS to provide quality medicines for 60+ years.
With an expanding portfolio of branded generic products covering multiple therapy areas, we are helping to maximise Primary Care budgets across the UK. By choosing Wockhardt as your reputable supplier of respiratory inhalers, you could benefit from excellent cost savings, responsive support and national distribution coverage. Talk to us and find out how Wockhardt UK’s branded generic medicines could benefit your patients, your prescribing budget and to get more information on our latest product launch. |